Cargando…

Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible

BACKGROUND: There is no consensus yet for the best treatment regimen in patients with recurrent rectal cancer (RRC). This study aims to evaluate toxicity and oncological outcomes after re-irradiation in patients with RRC in our center. Clinical (cCR) and pathological complete response (pCR) rates an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dijkstra, Esmée A., Mul, Véronique E. M., Hemmer, Patrick H. J., Havenga, Klaas, Hospers, Geke A. P., Muijs, Christina T., van Etten, Boudewijn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Colorectal Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349344/ https://www.ncbi.nlm.nih.gov/pubmed/34023946 http://dx.doi.org/10.1245/s10434-021-10070-6

Ejemplares similares

Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer of Patients with Prior Pelvic Irradiation
por: Yamada, Shigeru, et al.
Publicado: (2021)

Diagnostic accuracy of high-resolution MRI as a method to predict potentially safe endoscopic and surgical planes in patients with early rectal cancer
por: Balyasnikova, Svetlana, et al.
Publicado: (2017)

Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study
por: Hodges, Nicola, et al.
Publicado: (2022)

Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
por: Solbakken, Arne M., et al.
Publicado: (2023)

The Role of transanal (Ta) dissection in the management of difficult primary and recurrent rectal cancer
por: Courval, Valérie, et al.
Publicado: (2019)

Systematic Review of Patient-Reported Outcome Measures in Locally Recurrent Rectal Cancer
por: McKigney, Niamh, et al.
Publicado: (2023)

Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment
por: Maas, Monique, et al.
Publicado: (2015)

Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma
por: Hagemans, J. A. W., et al.
Publicado: (2019)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2021)

Optimal Treatment Strategy in Rectal Cancer Surgery: Should We Be Cowboys or Chickens?
por: Snijders, Heleen S., et al.
Publicado: (2015)

Snapshot Study on the Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer
por: Blok, Robin D., et al.
Publicado: (2017)

Exploration of Malignant Characteristics in Neoadjuvant Chemotherapy-Resistant Rectal Cancer, Focusing on Extramural Lesions
por: Kubota, Shunsuke, et al.
Publicado: (2023)

Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting
por: Sluckin, Tania C., et al.
Publicado: (2023)

Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
por: Zhou, Xuezhi, et al.
Publicado: (2019)

Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: D’Alimonte, Lucrezia, et al.
Publicado: (2020)

Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study
por: Rombouts, A. J. M., et al.
Publicado: (2016)

Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation
por: Cui, Christina Liu, et al.
Publicado: (2021)

Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study
por: Lambregts, Doenja M. J., et al.
Publicado: (2011)

Is the 1-cm Rule of Distal Bowel Resection Margin in Rectal Cancer Based on Clinical Evidence? A Systematic Review
por: Bujko, Krzysztof, et al.
Publicado: (2011)

The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer
por: Dreyer, Stephan B., et al.
Publicado: (2016)

Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes
por: Detering, Robin, et al.
Publicado: (2018)

Avoiding Unnecessary Major Rectal Cancer Surgery by Implementing Structural Restaging and a Watch-and-Wait Strategy After Neoadjuvant Radiochemotherapy
por: Huisman, J. F., et al.
Publicado: (2020)

Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis
por: Hoendervangers, S., et al.
Publicado: (2020)

2010 SSO John Wayne Clinical Research Lecture: Rectal Cancer Outcome Improvements in Europe: Population-Based Outcome Registrations will Conquer the World
por: van Gijn, W., et al.
Publicado: (2010)

Clinical Significance of Extramural Tumor Deposits in the Lateral Pelvic Lymph Node Area in Low Rectal Cancer: A Retrospective Study at Two Institutions
por: Yagi, Ryoma, et al.
Publicado: (2016)

Multiparametric MRI and Whole Slide Image-Based Pretreatment Prediction of Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Multicenter Radiopathomic Study
por: Shao, Lizhi, et al.
Publicado: (2020)

Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies
por: Belluco, Claudio, et al.
Publicado: (2011)

Primary Anastomosis Versus End-Ostomy in Left-Sided Colonic and Proximal Rectal Cancer Surgery in the Elderly Dutch Population: A Propensity Score Matched Analysis
por: van Loon, Yu Ting, et al.
Publicado: (2021)

Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response
por: Belluco, Claudio, et al.
Publicado: (2016)

T‐stage downstaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy is not associated with reduced recurrence after adjusting for tumour characteristics
por: Hayes, Ian P., et al.
Publicado: (2022)

Bevacizumab Efficacy in Metastatic Colorectal Cancer is Dependent on Primary Tumor Resection
por: Ghiringhelli, Francois, et al.
Publicado: (2014)

Identification of the Minimum Combination of Serum microRNAs to Predict the Recurrence of Colorectal Cancer Cases
por: Yoshikawa, Yukihiro, et al.
Publicado: (2022)

Locoregionally Recurrent Colon Cancer: How Far Have We Come? A Population-Based, Retrospective Cohort Study
por: Swartjes, Hidde, et al.
Publicado: (2022)

The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival
por: Höppener, Diederik J., et al.
Publicado: (2019)

Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells
por: Campregher, C, et al.
Publicado: (2008)

Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition
por: Fujisawa, T, et al.
Publicado: (2008)

Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature
por: Venderbosch, Sabine, et al.
Publicado: (2011)

K-Ras and MSI: Potential Markers of Both Patient Prognosis and Treatment Efficacy
por: Turaga, Kiran, et al.
Publicado: (2009)

Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening
por: Liedenbaum, M H, et al.
Publicado: (2009)

High Lymph Node Yield is Related to Microsatellite Instability in Colon Cancer
por: Belt, E. J. Th., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_r3nu8qkar23gcebpt1dr8t735f